Literature DB >> 12460344

'Superficial' bladder cancer - time to uncouple pT1 tumours from pTa tumours.

R T Bryan1, D M A Wallace.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12460344     DOI： 10.1046/j.1464-410x.2002.03053.x

Source DB:  PubMed          Journal:  BJU Int        ISSN： 1464-4096            Impact factor:   5.588


× No keyword cloud information.
  10 in total

1.  Multiprobe fluorescence in situ hybridisation: prognostic perspectives in superficial bladder cancer.

Authors:  C Mian; M Lodde; E Comploj; L Lusuardi; S Palermo; M Mian; K Maier; A Pycha
Journal:  J Clin Pathol       Date:  2006-09       Impact factor: 3.411

2.  Human epidermal growth factor receptor 2: a significant indicator for predicting progression in non-muscle-invasive bladder cancer especially in high-risk groups.

Authors:  Weihong Ding; Shijun Tong; Yuancheng Gou; Chuanyu Sun; Hong Wang; Zhongqing Chen; Jun Tan; Ke Xu; Guowei Xia; Qiang Ding
Journal:  World J Urol       Date:  2015-04-18       Impact factor: 4.226

3.  Snail is an independent prognostic indicator for predicting recurrence and progression in non-muscle-invasive bladder cancer.

Authors:  Yuancheng Gou; Weihong Ding; Ke Xu; Hong Wang; Zhongqing Chen; Jun Tan; Guowei Xia; Qiang Ding
Journal:  Int Urol Nephrol       Date:  2014-11-12       Impact factor: 2.370

4.  Growth pattern in superficial urothelial bladder carcinomas. Histological review and clinical relevance.

Authors:  José I López; Javier C Angulo
Journal:  Int Urol Nephrol       Date:  2009-03-12       Impact factor: 2.370

5.  Predicting recurrence and progression of noninvasive papillary bladder cancer at initial presentation based on quantitative gene expression profiles.

Authors:  Marc Birkhahn; Anirban P Mitra; Anthony J Williams; Gitte Lam; Wei Ye; Ram H Datar; Marija Balic; Susan Groshen; Kenneth E Steven; Richard J Cote
Journal:  Eur Urol       Date:  2009-09-09       Impact factor: 20.096

Review 6.  Molecular screening for bladder cancer: progress and potential.

Authors:  Anirban P Mitra; Richard J Cote
Journal:  Nat Rev Urol       Date:  2010-01       Impact factor: 14.432

7.  MicroRNA Expression Profile Identifies High Grade, Non-Muscle-Invasive Bladder Tumors at Elevated Risk to Progress to an Invasive Phenotype.

Authors:  Sara M Lenherr; Sheaumei Tsai; Brasil Silva Neto; Travis B Sullivan; Cara B Cimmino; Tanya Logvinenko; Jason Gee; Wei Huang; John A Libertino; Ian C Summerhayes; Kimberly M Rieger-Christ
Journal:  Genes (Basel)       Date:  2017-02-17       Impact factor: 4.096

Review 8.  Microsatellite Instability Analysis (MSA) for Bladder Cancer: Past History and Future Directions.

Authors:  Chulso Moon; Maxie Gordon; David Moon; Thomas Reynolds
Journal:  Int J Mol Sci       Date:  2021-11-28       Impact factor: 5.923

9.  The 1973 WHO Classification is more suitable than the 2004 WHO Classification for predicting prognosis in non-muscle-invasive bladder cancer.

Authors:  Zhongqing Chen; Weihong Ding; Ke Xu; Jun Tan; Chuanyu Sun; Yuancheng Gou; Shijun Tong; Guowei Xia; Zujun Fang; Qiang Ding
Journal:  PLoS One       Date:  2012-10-17       Impact factor: 3.240

10.  A patient-derived orthotopic xenograft model enabling human high-grade urothelial cell carcinoma of the bladder tumor implantation, growth, angiogenesis, and metastasis.

Authors:  Jessie Gills; Ravan Moret; Xin Zhang; John Nelson; Grace Maresh; Linh Hellmers; Daniel Canter; M'Liss Hudson; Shams Halat; Marc Matrana; Michael P Marino; Jakob Reiser; Maureen Shuh; Eric Laborde; Maria Latsis; Sunil Talwar; Stephen Bardot; Li Li
Journal:  Oncotarget       Date:  2018-08-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.